Inventor · disambiguated record
Serge Lebecque
Also filed as: LEBECQUE SERGE · LEBECQUE SERGE J · LEBECQUE SERGE J E · LEBECQUE SERGE JOSEPH EMMA
15 granted patents·5 pending applications·95 citations·filing 1984–2022
91Inventor score
Files withSCHERING CORP11CENTRE LEON BERARD4LEBECQUE SERGE3INT INST CELLULAR MOLECUL PATH1INTERNAT INST OF CELLULAR AND1
Top patents by PatentIndex Score
20 records- 0188US6756478B2Isolated mammalian membrane protein genes; related reagentsSCHERING CORP·Filed 2001·Granted Jun 29, 2004·16 cites·8 claims
- 0285US6277959B1Isolated mammalian membrane protein genes; related reagentsSCHERING CORP·Filed 1998·Granted Aug 21, 2001·39 cites·16 claims
- 0372US6933369B2Mammalian proteinases; oxidoreductases; related reagentsSCHERING CORP·Filed 2003·Granted Aug 23, 2005·4 cites·5 claims
- 0466US7034137B2Isolated mammalian membrane protein genes; related reagentsSCHERING CORP·Filed 2004·Granted Apr 25, 2006·0 cites·10 claims
- 0565US7691373B2Isolated mammalian membrane proteins; related agentsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·0 cites·23 claims
- 0665US4740371ATreatment of allergyINT INST CELLULAR MOLECUL PATH·Filed 1984·Granted Apr 26, 1988·26 cites·18 claims
- 0761US7179467B2DCMP2 polypeptideSCHERING CORP·Filed 2005·Granted Feb 20, 2007·0 cites·4 claims
- 0859US12509465B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2022·Granted Dec 30, 2025·0 cites·17 claims
- 0949US2012045523A1Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic "apoptosis" pathway in the treatment of cancerLEBECQUE SERGE·Filed 2009·Application pending·0 cites
- 1047US2005142619A1Antibodies to mammalian langerhans cell antigen and their usesSCHERING CORP·Filed 2005·Application pending·0 cites
- 1146US11384081B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2017·Granted Jul 12, 2022·0 cites·15 claims
- 1245US2009285779A1Induction of apoptosis in toll-like receptor expressing tumor cellsLEBECQUE SERGE·Filed 2007·Application pending·0 cites
- 1343US2006147456A1Induction of apoptosis in toll-like receptor expressing tumor cellsLEBECQUE SERGE·Filed 2005·Application pending·0 cites
- 1441US7354705B2Methods for cancer prognosis and diagnosisSCHERING CORP·Filed 2004·Granted Apr 8, 2008·0 cites·5 claims
- 1541US6878528B1Polynucleotides encoding a mammalian Langerhans cell antigenSCHERING CORP·Filed 1999·Granted Apr 12, 2005·3 cites·6 claims
- 1639US6361939B1Isolated mammalian dendritic cell genes; related reagentsSCHERING CORP·Filed 1997·Granted Mar 26, 2002·7 cites·16 claims
- 1736US2019292546A1Tlr3 agonist for use for inducing apoptosis in senescent cancer cellsCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
- 1834US9683986B2Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interactionCENTRE LEON BERARD·Filed 2012·Granted Jun 20, 2017·0 cites·10 claims
- 1931US6812004B1Mammalian dendritic cell chemokine reagentsSCHERING CORP·Filed 1997·Granted Nov 2, 2004·0 cites·9 claims
- 2016US7122380B1Pharmaceutical compositions containing antigen-antibody complexes and uses thereforINTERNAT INST OF CELLULAR AND·Filed 1994·Granted Oct 17, 2006·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Serge Lebecque files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →